NEW YORK, Aug. 8 – CombiMatrix will see its microarrays launched into space in a deal with the NASA Ames Research Center, the company said on Wednesday.

The National Aeronautics and Space Administration has agreed to license and purchase CombiMatrix’s active biochips and technology to use in biological research in ground-based labs and aboard the International Space Station. 

Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.